Skip to main content
Subscribe
Log In
More
Log in via Institution
Log in via OpenAthens
Log in via your Society
Select your society
ESGO
IGCS
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Current issue
Archive
Authors
About
YouTube
Podcasts
Zoom Journal Club
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Current issue
Archive
Authors
About
YouTube
Podcasts
Zoom Journal Club
Subscribe
Log in
More
Log in via Institution
Log in via OpenAthens
Log in via your Society
Select your society
ESGO
IGCS
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
platinum resistance
Email alerts
platinum resistance
An Outpatient, Dose-Intense, Intravenous Cisplatin and Oral Etoposide Regimen for the Treatment of Advanced, Platinum-Resistant Ovarian Cancer
Robert D.
Morgan
,
Andrew R.
Clamp
,
Jurjees
Hasan
,
Claire
Mitchell
,
Geoff
Saunders
,
Nerissa
Mescallado
,
Richard
Welch
,
Gordon C.
Jayson
International Journal of Gynecologic Cancer
Mar 2018,
28
(3)
448-452;
DOI:
10.1097/IGC.0000000000001194
Panitumumab and Pegylated Liposomal Doxorubicin in Platinum-Resistant Epithelial Ovarian Cancer With KRAS Wild-Type: The PaLiDo Study, a Phase II Nonrandomized Multicenter Study
Karina Dahl
Steffensen
,
Marianne
Waldstrøm
,
Niels
Pallisgård
,
Bente
Lund
,
Kjell
Bergfeldt
,
Jessica
Wihl
,
Nina
Keldsen
,
Christian
Marth
,
Ignace
Vergote
,
Anders
Jakobsen
International Journal of Gynecologic Cancer
Jan 2013,
23
(1)
73-80;
DOI:
10.1097/IGC.0b013e3182775fae
Prognostic factors associated with response in platinum retreatment of platinum-resistant ovarian cancer
T. T.
Nguyen
,
J. D.
Wright
,
M. A.
Powell
,
R. K.
Gibb
,
J. S.
Rader
,
J. E.
Allsworth
,
D. G.
Mutch
International Journal of Gynecologic Cancer
Oct 2008,
18
(6)
1194-1199;
DOI:
10.1111/j.1525-1438.2007.01184.x
Retrospective review: re-treatment of patients with ovarian cancer with carboplatin after platinum resistance
H. T.
See
,
R. S.
Freedman
,
A. P.
Kudelka
,
T. W.
Burke
,
D. M.
Gershenson
,
S.
Tangjitgamol
,
J. J.
Kavanagh
International Journal of Gynecologic Cancer
Feb 2005,
15
(2)
209-216;
DOI:
10.1136/ijgc-00009577-200503000-00004
Weekly paclitaxel in patients with recurrent or persistent advanced ovarian cancer
S.
Ghamande
,
S.
Lele
,
D.
Marchetti
,
T.
Baker
,
K.
Odunsi
International Journal of Gynecologic Cancer
Feb 2003,
13
(2)
142-147;
DOI:
10.1136/ijgc-00009577-200303000-00007
Veliparib Monotherapy to Patients With
BRCA
Germ Line Mutation and Platinum-Resistant or Partially Platinum-Sensitive Relapse of Epithelial Ovarian Cancer: A Phase I/II Study
Karina Dahl
Steffensen
,
Parvin
Adimi
,
Anders
Jakobsen
International Journal of Gynecologic Cancer
Nov 2017,
27
(9)
1842-1849;
DOI:
10.1097/IGC.0000000000001089
Platelet-Derived Growth Factor D Is a Prognostic Biomarker and Is Associated With Platinum Resistance in Epithelial Ovarian Cancer
Mengjun
Zhang
,
Tianbo
Liu
,
Bairong
Xia
,
Chunyan
Yang
,
Siyu
Hou
,
Wanlin
Xie
,
Ge
Lou
International Journal of Gynecologic Cancer
Feb 2018,
28
(2)
323-331;
DOI:
10.1097/IGC.0000000000001171
The Prognostic and Predictive Value of Combined HE4 and CA-125 in Ovarian Cancer Patients
Karina Dahl
Steffensen
,
Marianne
Waldstrøm
,
Ivan
Brandslund
,
Max
Petzold
,
Anders
Jakobsen
International Journal of Gynecologic Cancer
Nov 2012,
22
(9)
1474-1482;
DOI:
10.1097/IGC.0b013e3182681cfd
A phase II trial of intravenous etoposide (VP-16-213) in epithelial ovarian cancer resistant to cisplatin or carboplatin: clinical and serological evidence of activity
P. J.
HOSKINS
,
E.
McMURTRIE
,
K. D.
SWENERTON
International Journal of Gynecologic Cancer
Jan 1992,
2
(1)
35-40;
DOI:
10.1046/j.1525-1438.1992.02010035.x
ATL
Tamar
Safra
,
Ori
Rogowski
,
Franco M.
Muggia
International Journal of Gynecologic Cancer
Mar 2014,
24
(3)
488-495;
DOI:
10.1097/IGC.0000000000000086
Special collections
Editor's choice
(186)
Guidelines, Recommendations and Consensus Statements
IJGC
Case Study
(17)
Cervical Cancer
(20)
Clinical Trial
(108)
Corners of the World
(23)
Endometrial Cancer
Fertility and Pregnancy
Lay summaries
(1)
Lead articles
(13)
Ovarian Cancer
(35)
Palliative Care
Perioperative Care
Preinvasive Disease
(1)
Review
(28)
Surgical Outcomes
Uterine Cancer
(16)
Video Article
(178)
Vulvar Cancer
(2)
Open access
(269)
Press releases
(4)